Venus Remedies has strengthened its footprint in the Gulf region after receiving Marketing Authorization from the Saudi Food and Drug Authority for Plerixafor, a specialty injectable used in stem cell transplantation procedures.
The pharmaceutical outsourcing landscape is undergoing its most consequential structural transformation in decades—and Indian CDMO players are leading the charge. As global drug innovators race to compress timelines and de-risk capital-intensive...
India-US cooperation is rapidly becoming a key driver of innovation in biotech and healthcare, with both nations expanding partnerships in biotechnology, nuclear medicine, advanced research, and healthcare technology.
Strides Pharma Science Ltd today announced its consolidated financial results for the quarter (Q4FY26) and Full Year (FY26) ended March 31, 2026. Badree Komandur, MD & Group CEO, commented on the performance and said, “Strides continued to deliver...
Glenmark Pharmaceuticals announced the launch of its affordable Vancomycin Hydrochloride for Injection USP in the U.S. market in two strengths, 500 mg/vial and 1 g/vial.
The Pharma Quality Excellence Awards 2026 marked another significant milestone in recognizing excellence in pharmaceutical quality and innovation. Hosted at Hotel Westin Mumbai Garden City
At a time when the pharmaceutical industry is navigating increasing regulatory scrutiny, rapid digitalization, and growing expectations around trust and transparency, the conversation around quality is evolving.
Alembic Pharma shares gained attention on Wednesday after the company announced that it had received tentative approval from the United States Food and Drug Administration (USFDA) for Darolutamide Tablets 300 mg, a treatment used for prostate cancer.
Dr Reddy’s Laboratories is expanding its semaglutide generic franchise while trimming parts of its oncology pipeline as the company sharpens its focus on the fast-growing obesity treatment market and diabetes care segment.
SwishX, a Bengaluru-based startup backed by $2.2M in seed funding, launches the world's first agentic AI platform to modernise pharma and medtech sales, marketing, and distribution across a $400 billion emerging market opportunity.
.jpg)
.jpg)
, CDSCO.jpg)